The Association of the manufacturers of innovative drugs INOVIA was founded in February 2007. Members of the Association are innovative pharmaceutical companies that are doing business in Serbia.
INOVIA Mission is to promote technological and economical development of innovative pharmaceutical industry in Serbia and, as leaders in that field, we are devoted to cooperate with all relevant entites that can affect improvement of the Serbian healthcare system. Since 2009, INOVIA is a member of EFPIA, European Federation of Pharmaceutical Industries and Associations, whose codes automatically became mandatory for all member companies of the INOVIA Association.
INOVIA basic mission is to promote technological and economic development of the pharmaceutical industry in the Republic of Serbia and assistance in bringing medical products that improve human health worldwide to the market.
INOVIA objectives are the promotion of education, activities and habits for better health and quality of life, establishing a transparent dialogue and partnerships with leading government and non-governmental organizations in Serbia in order to identify and implement best practice.
One of the initiatives of INOVIA is the adoption of the Code of Conduct in promoting drugs that are prescribed and dispensed by prescription and in communication with healthcare professionals. The Code signatories are all INOVIA members.
The detailed provisions in the Code should ensure that pharmaceutical companies operate in a responsible, ethical and professional manner.
Ivan Krpić (Janssen), President of the Board of Directors
Ana Govedarica (Roche), Vice President of the Board of Directors
Nikola Stojković (Novartis), Member of the Board of Directors
Nebojša Škuljec (MSD), Member of the Board of Directors
Aleksandar Tripković (AstraZeneca), Member of the Board of Directors
Milena Argirović (Takeda), Member of the Supervisory board
Ina Bulat (Merck), Member of the Supervisory board
Una Ljubičić (Pfizer), Member of the Supervisory board
